Eloxx Pharmaceuticals, Inc. Quarterly Common Stock, Shares Authorized from Q2 2011 to Q3 2023

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Eloxx Pharmaceuticals, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q2 2011 to Q3 2023.
  • Eloxx Pharmaceuticals, Inc. Common Stock, Shares Authorized for the quarter ending September 30, 2023 was 500M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 500M 0 0% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 500M 0 0% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 500M 0 0% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 500M 0 0% Dec 31, 2022 10-Q 2023-11-13
Q3 2022 500M 0 0% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 500M 0 0% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 500M 0 0% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 500M 0 0% Dec 31, 2021 10-K 2023-03-31
Q3 2021 500M 0 0% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 500M 0 0% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 500M 0 0% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 500M 0 0% Dec 31, 2020 10-K 2022-03-30
Q3 2020 500M 0 0% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 500M 0 0% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 500M 0 0% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 500M 0 0% Dec 31, 2019 10-K 2021-03-12
Q3 2019 500M 0 0% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 500M 0 0% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 500M 0 0% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 500M 0 0% Dec 31, 2018 10-K 2020-03-06
Q3 2018 500M 0 0% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 500M 0 0% Jun 30, 2018 10-Q 2018-08-10
Q1 2018 500M 0 0% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 500M +470M +1570% Dec 31, 2017 10-K 2019-03-14
Q3 2017 500M 0 0% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 500M 0 0% Jun 30, 2017 10-Q 2017-11-14
Q1 2017 500M 0 0% Mar 31, 2017 10-Q 2017-05-22
Q4 2016 29.9M -470M -94% Dec 31, 2016 10-K 2018-03-16
Q3 2016 500M 0 0% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 500M 0 0% Jun 30, 2016 10-K 2017-10-13
Q1 2016 500M 0 0% Mar 31, 2016 10-Q 2016-05-12
Q4 2015 500M 0 0% Dec 31, 2015 10-Q 2016-02-16
Q3 2015 500M 0 0% Sep 30, 2015 10-Q 2015-11-16
Q2 2015 500M 0 0% Jun 30, 2015 10-K 2016-10-13
Q1 2015 500M 0 0% Mar 31, 2015 10-Q 2015-05-14
Q4 2014 500M 0 0% Dec 31, 2014 10-Q 2015-02-17
Q3 2014 500M 0 0% Sep 30, 2014 10-Q 2014-11-14
Q2 2014 500M 0 0% Jun 30, 2014 10-K 2015-10-09
Q1 2014 500M +150M +42.9% Mar 31, 2014 10-Q 2014-05-09
Q4 2013 500M +150M +42.9% Dec 31, 2013 10-Q 2014-02-14
Q3 2013 500M +150M +42.9% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 500M 0 0% Jun 30, 2013 10-K 2014-09-29
Q1 2013 350M 0 0% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 350M 0 0% Dec 31, 2012 10-Q 2013-02-14
Q3 2012 350M +100M +40% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 500M +150M +42.9% Jun 30, 2012 10-K 2013-09-11
Q1 2012 350M Mar 31, 2012 10-Q 2012-05-14
Q4 2011 350M Dec 31, 2011 10-Q 2012-02-14
Q3 2011 250M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 350M Jun 30, 2011 10-K/A 2012-10-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.